HydroPeptide SPOT CORRECTION

Manufacturer: Bentley Laboratories, LLC
Effective date: 2018-12-19
Label type: HUMAN OTC DRUG LABEL
Version: 2
Source: legacy-cache
Hydrated at: 2026-08-02 00:40:30

Label at a glance#

ProductHydroPeptide SPOT CORRECTION

Active ingredientSULFUR

Label structure13 sections

Indications and uses

treat acne helps prevent new pimples clears up most acne pimples

Dosage and administration

clean skin thoroughly before applying this product cover the entire affected area with a thin layer one to three times daily because excessive drying of the skin may occur, start with one application, then gradually increase to two or three times daily if needed or as directed by a doctor if bothersome dryness or peeling ocurs, reduce application to once a day or every other day

Contacts and useful links#

PhoneLabel contact1-800-932-9873

Websitewww.hydropeptide.com

WWW.HYDROPEPTIDE.COM

Label contents#

Full prescribing information#

Drug Facts Active ingredients

OTC - ACTIVE INGREDIENT SECTION

Colloidal Sulfur (3%)

Purpose

OTC - PURPOSE SECTION

Acne treatment ointment

Keep out of reach of children.

OTC - KEEP OUT OF REACH OF CHILDREN SECTION

Keep out of reach of children. If swallowed, get medical help or contact a Poison Control Center right away.

Uses

INDICATIONS & USAGE SECTION

treat acne
helps prevent new pimples
clears up most acne pimples

Warnings

WARNINGS SECTION

For external use only

Do not use on

OTC - DO NOT USE SECTION

broken skin
large areas of the body

When applying this product

OTC - WHEN USING SECTION

apply only to area with acne
rinse right away with water if it gets in eyes
skin irritation and dryness is more likely to occur if you use another topical acne medication at the same time. If irritation occurs, only use one topical acne medication at a time.

Stop use and ask a doctor if

OTC - STOP USE SECTION

skin irritation occurs or gets worse

Directions

DOSAGE & ADMINISTRATION SECTION

clean skin thoroughly before applying this product
cover the entire affected area with a thin layer one to three times daily
because excessive drying of the skin may occur, start with one application, then gradually increase to two or three times daily if needed or as directed by a doctor
if bothersome dryness or peeling ocurs, reduce application to once a day or every other day

Other information

OTHER SAFETY INFORMATION

store at controlled room temperature (59° - 86°F)

Inactive ingredients

INACTIVE INGREDIENT SECTION

4-t-Butylcyclohexanol, Acacia Senegal Gum, Arginine, Chondrus Crispus (Carrageenan), Citrus Grandis (Grapefruit) Peel Oil, pilobium Angustifolium Flower/Leaf/Stem Extract, Lactic Acid, Leuconostoc/radish Root Ferment Filtrate, Melaleuca Alternifolia (Tea Tree) Leak Oil, Niacinamide, Pentylene Glycol, Rice Ferment (Sake) Filtrate, Sodium Hydroxide, Water (Aqua), Xanthan Gum

Questions or comments?

OTC - QUESTIONS SECTION

Call 1-800-932-9873

HydroPeptide SPOT CORRECTION Product Label

PACKAGE LABEL.PRINCIPAL DISPLAY PANEL

HydroPeptide®

SPOT CORRECTION

Acne Eliminating Treatment
Anti-Wrinkle + Clarify

0.5 FL OZ / e15 mL

VRL Technology

Peptide Variety

Clinical Levels

Repetition and Layering

HydroPeptide® is the leader in anti-aging skincare with our proprietary VLR technology; using the correct variety of peptides at clinical levels with continuous repetition for superior anti-aging results

Colloidal Sulfur, Lactic Acid, Sake Peptide

This advanced formula combines acne fighting and anti-aging ingredients that clear up acne pimples and prevent new ones from forming without over-drying the affected area

GLUTEN FREE, PARABEN FREE, PHTHALATE FREE
FOR ALL SKIN TYPES, NOT TESTED ON ANIMALS

DIST. BY PREMIER HEALTHSOURCE, INC.
ISSAQUAH, WA 98027

RP. MSL, BL9 5NB, UK
MADE IN THE USA

WWW.HYDROPEPTIDE.COM

HydroPeptide1 Label

HydroPeptide2 Label

DailyMed Socrata Ingredients#

Ingredient, Type, UNII table
Ingredient	Type	UNII	SPL version
SULFUR	ACTIVE INGREDIENT	70FD1KFU70	1
SULFUR	ACTIVE MOIETY	70FD1KFU70	1
4-TERT-BUTYLCYCLOHEXANOL	INACTIVE INGREDIENT	K0H1405S9C	1
ACACIA	INACTIVE INGREDIENT	5C5403N26O	1
ARGININE	INACTIVE INGREDIENT	94ZLA3W45F	1
CHONDRUS CRISPUS CARRAGEENAN	INACTIVE INGREDIENT	UE856F2T78	1
CITRUS MAXIMA FRUIT RIND OIL	INACTIVE INGREDIENT	8U3877WD44	1
EPILOBIUM ANGUSTIFOLIUM FLOWERING TOP	INACTIVE INGREDIENT	08H094218D	1
LACTIC ACID	INACTIVE INGREDIENT	33X04XA5AT	1
LEUCONOSTOC/RADISH ROOT FERMENT FILTRATE	INACTIVE INGREDIENT	D2QHA03458	1
NIACINAMIDE	INACTIVE INGREDIENT	25X51I8RD4	1
ORYZA SATIVA WHOLE	INACTIVE INGREDIENT	84IVV0906Z	1
PENTYLENE GLYCOL	INACTIVE INGREDIENT	50C1307PZG	1
SODIUM HYDROXIDE	INACTIVE INGREDIENT	55X04QC32I	1
TEA TREE OIL	INACTIVE INGREDIENT	VIF565UC2G	1
WATER	INACTIVE INGREDIENT	059QF0KO0R	1
XANTHAN GUM	INACTIVE INGREDIENT	TTV12P4NEE	1

Products#

Every source-derived product name is available through these pages.

DailyMed product names page 1 of 1 · 17 matching rows.

HydroPeptide SPOT CORRECTION
SULFUR
4-TERT-BUTYLCYCLOHEXANOL
ACACIA
ARGININE
CHONDRUS CRISPUS CARRAGEENAN
CITRUS MAXIMA FRUIT RIND OIL
EPILOBIUM ANGUSTIFOLIUM FLOWERING TOP
LACTIC ACID
LEUCONOSTOC/RADISH ROOT FERMENT FILTRATE
TEA TREE OIL
NIACINAMIDE
PENTYLENE GLYCOL
ORYZA SATIVA WHOLE
SODIUM HYDROXIDE
WATER
XANTHAN GUM

NDC Codes#

Product NDC, Package NDC table
Product NDC	Package NDC
54111-117	54111-117-50

Ingredients#

Every source-derived ingredient row is available through these pages.

DailyMed ingredient rows page 1 of 1 · 16 matching rows.

Name, UNII, Kind table
Name	UNII	Kind
SULFUR	70FD1KFU70	ACTIB
4-TERT-BUTYLCYCLOHEXANOL	K0H1405S9C	IACT
ACACIA	5C5403N26O	IACT
ARGININE	94ZLA3W45F	IACT
CHONDRUS CRISPUS CARRAGEENAN	UE856F2T78	IACT
CITRUS MAXIMA FRUIT RIND OIL	8U3877WD44	IACT
EPILOBIUM ANGUSTIFOLIUM FLOWERING TOP	08H094218D	IACT
LACTIC ACID	33X04XA5AT	IACT
LEUCONOSTOC/RADISH ROOT FERMENT FILTRATE	D2QHA03458	IACT
TEA TREE OIL	VIF565UC2G	IACT
NIACINAMIDE	25X51I8RD4	IACT
PENTYLENE GLYCOL	50C1307PZG	IACT
ORYZA SATIVA WHOLE	84IVV0906Z	IACT
SODIUM HYDROXIDE	55X04QC32I	IACT
WATER	059QF0KO0R	IACT
XANTHAN GUM	TTV12P4NEE	IACT

Source Document#

Source XML

Inactive ingredient matches#

Inactive Ingredient Database values describe FDA-listed use contexts. The match method and ambiguity count are shown because ingredient names, routes, and dosage forms are not always unique. Browse recovered IID releases and source provenance.

Inactive ingredient links page 1 of 5 · 255 matching rows.

DailyMed ingredient, IID ingredient, UNII table
DailyMed ingredient	IID ingredient	UNII	Dosage form / route	Potency	Maximum daily exposure	Match
SODIUM HYDROXIDE	SODIUM HYDROXIDE	55X04QC32I	LIQUID / ORAL	2 mg/5ml		Exact identifier — unii candidate 174 equally ranked IID candidates
SODIUM HYDROXIDE	SODIUM HYDROXIDE	55X04QC32I	JELLY / TOPICAL	ADJ PH		Exact identifier — unii candidate 174 equally ranked IID candidates
LACTIC ACID	LACTIC ACID	33X04XA5AT	CONCENTRATE / ORAL	50 mg/5ml		Exact identifier — unii candidate 18 equally ranked IID candidates
LACTIC ACID	LACTIC ACID	33X04XA5AT	AEROSOL, FOAM / TOPICAL		11 mg	Exact identifier — unii candidate 18 equally ranked IID candidates
SODIUM HYDROXIDE	SODIUM HYDROXIDE	55X04QC32I	SOLUTION / DENTAL	ADJ PH		Exact identifier — unii candidate 174 equally ranked IID candidates
SODIUM HYDROXIDE	SODIUM HYDROXIDE	55X04QC32I	INJECTION / INTRA-ARTICULAR	ADJ PH		Exact identifier — unii candidate 174 equally ranked IID candidates
SODIUM HYDROXIDE	SODIUM HYDROXIDE	55X04QC32I	INJECTION, POWDER, FOR SUSPENSION / INTRAVENOUS	ADJ PH		Exact identifier — unii candidate 174 equally ranked IID candidates
ACACIA	ACACIA	5C5403N26O	GUM, CHEWING / BUCCAL		280 mg	Exact identifier — unii candidate 19 equally ranked IID candidates
SODIUM HYDROXIDE	SODIUM HYDROXIDE	55X04QC32I	ENEMA / RECTAL	0.44 %v/v		Exact identifier — unii candidate 174 equally ranked IID candidates
SODIUM HYDROXIDE	SODIUM HYDROXIDE	55X04QC32I	INJECTION, SUSPENSION, EXTENDED RELEASE / INTRAMUSCULAR		27 mg	Exact identifier — unii candidate 174 equally ranked IID candidates
SODIUM HYDROXIDE	SODIUM HYDROXIDE	55X04QC32I	INJECTION / INTRADERMAL	ADJ PH		Exact identifier — unii candidate 174 equally ranked IID candidates
SODIUM HYDROXIDE	SODIUM HYDROXIDE	55X04QC32I	SOLUTION / URETHRAL	ADJ PH		Exact identifier — unii candidate 174 equally ranked IID candidates
SODIUM HYDROXIDE	SODIUM HYDROXIDE	55X04QC32I	LIQUID / INTRAVENOUS	ADJ PH		Exact identifier — unii candidate 174 equally ranked IID candidates
XANTHAN GUM	XANTHAN GUM	TTV12P4NEE	POWDER, FOR SOLUTION / ORAL	10 mg/5ml		Exact identifier — unii candidate 29 equally ranked IID candidates
SODIUM HYDROXIDE	SODIUM HYDROXIDE	55X04QC32I	INJECTION, POWDER, FOR SOLUTION / INTRAMUSCULAR	7.01 mg		Exact identifier — unii candidate 174 equally ranked IID candidates
SODIUM HYDROXIDE	SODIUM HYDROXIDE	55X04QC32I	INJECTION / INTRAPERITONEAL	ADJ PH		Exact identifier — unii candidate 174 equally ranked IID candidates
XANTHAN GUM	XANTHAN GUM	TTV12P4NEE	SUSPENSION, EXTENDED RELEASE / ORAL	186.8 mg		Exact identifier — unii candidate 29 equally ranked IID candidates
ARGININE	ARGININE	94ZLA3W45F	INJECTION, POWDER, FOR SOLUTION / INTRAVENOUS		3600 mg	Exact identifier — unii candidate 11 equally ranked IID candidates
ACACIA	ACACIA	5C5403N26O	TABLET, COATED / ORAL	156 mg		Exact identifier — unii candidate 19 equally ranked IID candidates
XANTHAN GUM	XANTHAN GUM	TTV12P4NEE	TABLET / ORAL		56 mg	Exact identifier — unii candidate 29 equally ranked IID candidates
SODIUM HYDROXIDE	SODIUM HYDROXIDE	55X04QC32I	INJECTION / INTRASPINAL	ADJ PH		Exact identifier — unii candidate 174 equally ranked IID candidates
SODIUM HYDROXIDE	SODIUM HYDROXIDE	55X04QC32I	TABLET, COATED / ORAL	NA		Exact identifier — unii candidate 174 equally ranked IID candidates
SODIUM HYDROXIDE	SODIUM HYDROXIDE	55X04QC32I	GEL / TRANSDERMAL		472 mg	Exact identifier — unii candidate 174 equally ranked IID candidates
SODIUM HYDROXIDE	SODIUM HYDROXIDE	55X04QC32I	INJECTION, EMULSION / INTRAVENOUS	ADJ PH		Exact identifier — unii candidate 174 equally ranked IID candidates
XANTHAN GUM	XANTHAN GUM	TTV12P4NEE	LOTION / TOPICAL	0.3 %w/v		Exact identifier — unii candidate 29 equally ranked IID candidates
SODIUM HYDROXIDE	SODIUM HYDROXIDE	55X04QC32I	CREAM / VAGINAL	0.19 %w/w		Exact identifier — unii candidate 174 equally ranked IID candidates
SODIUM HYDROXIDE	SODIUM HYDROXIDE	55X04QC32I	SOLUTION / NASAL	20 mg		Exact identifier — unii candidate 174 equally ranked IID candidates
SODIUM HYDROXIDE	SODIUM HYDROXIDE	55X04QC32I	CAPSULE, COATED PELLETS / ORAL	0.01 mg		Exact identifier — unii candidate 174 equally ranked IID candidates
LACTIC ACID	LACTIC ACID	33X04XA5AT	SUPPOSITORY / VAGINAL	NA		Exact identifier — unii candidate 18 equally ranked IID candidates
SODIUM HYDROXIDE	SODIUM HYDROXIDE	55X04QC32I	SOLUTION, CONCENTRATE / INTRAVENOUS	ADJ PH		Exact identifier — unii candidate 174 equally ranked IID candidates
SODIUM HYDROXIDE	SODIUM HYDROXIDE	55X04QC32I	INJECTION, SOLUTION / EPIDURAL	ADJ PH		Exact identifier — unii candidate 174 equally ranked IID candidates
SODIUM HYDROXIDE	SODIUM HYDROXIDE	55X04QC32I	TABLET, DELAYED RELEASE / ORAL		4 mg	Exact identifier — unii candidate 174 equally ranked IID candidates
XANTHAN GUM	XANTHAN GUM	TTV12P4NEE	TROCHE / ORAL		948 mg	Exact identifier — unii candidate 29 equally ranked IID candidates
SODIUM HYDROXIDE	SODIUM HYDROXIDE	55X04QC32I	INJECTION / INTRACAVITARY	ADJ PH		Exact identifier — unii candidate 174 equally ranked IID candidates
SODIUM HYDROXIDE	SODIUM HYDROXIDE	55X04QC32I	INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION / SUBCUTANEOUS	ADJ PH		Exact identifier — unii candidate 174 equally ranked IID candidates
ACACIA	ACACIA	5C5403N26O	SYRUP / ORAL	NA		Exact identifier — unii candidate 19 equally ranked IID candidates
SODIUM HYDROXIDE	SODIUM HYDROXIDE	55X04QC32I	SOLUTION / TOPICAL		39 mg	Exact identifier — unii candidate 174 equally ranked IID candidates
ACACIA	ACACIA	5C5403N26O	POWDER / ORAL	800 mg		Exact identifier — unii candidate 19 equally ranked IID candidates
SODIUM HYDROXIDE	SODIUM HYDROXIDE	55X04QC32I	POWDER, FOR SOLUTION / ORAL	ADJ PH		Exact identifier — unii candidate 174 equally ranked IID candidates
SODIUM HYDROXIDE	SODIUM HYDROXIDE	55X04QC32I	INJECTION, SOLUTION / SUBCUTANEOUS	1 %w/v		Exact identifier — unii candidate 174 equally ranked IID candidates
SODIUM HYDROXIDE	SODIUM HYDROXIDE	55X04QC32I	INJECTION, SOLUTION / INTRAVASCULAR	ADJ PH		Exact identifier — unii candidate 174 equally ranked IID candidates
SODIUM HYDROXIDE	SODIUM HYDROXIDE	55X04QC32I	OINTMENT, AUGMENTED / TOPICAL	0.11 %w/w		Exact identifier — unii candidate 174 equally ranked IID candidates
SODIUM HYDROXIDE	SODIUM HYDROXIDE	55X04QC32I	GRANULE, FOR SUSPENSION / ORAL	ADJ PH		Exact identifier — unii candidate 174 equally ranked IID candidates
ARGININE	ARGININE	94ZLA3W45F	INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION / INTRAMUSCULAR		6240 mg	Exact identifier — unii candidate 11 equally ranked IID candidates
XANTHAN GUM	XANTHAN GUM	TTV12P4NEE	TABLET, CHEWABLE, EXTENDED RELEASE / ORAL		6 mg	Exact identifier — unii candidate 29 equally ranked IID candidates
SODIUM HYDROXIDE	SODIUM HYDROXIDE	55X04QC32I	TABLET, FILM COATED / ORAL		8 mg	Exact identifier — unii candidate 174 equally ranked IID candidates
XANTHAN GUM	XANTHAN GUM	TTV12P4NEE	SUSPENSION / RECTAL		452 mg	Exact identifier — unii candidate 29 equally ranked IID candidates
SODIUM HYDROXIDE	SODIUM HYDROXIDE	55X04QC32I	FILM, EXTENDED RELEASE / TRANSDERMAL	0.85 mg		Exact identifier — unii candidate 174 equally ranked IID candidates
SODIUM HYDROXIDE	SODIUM HYDROXIDE	55X04QC32I	FILM / BUCCAL	0.09 mg		Exact identifier — unii candidate 174 equally ranked IID candidates
SODIUM HYDROXIDE	SODIUM HYDROXIDE	55X04QC32I	SPRAY, METERED / NASAL	ADJ PH		Exact identifier — unii candidate 174 equally ranked IID candidates
ACACIA	ACACIA	5C5403N26O	TABLET / ORAL	70 mg		Exact identifier — unii candidate 19 equally ranked IID candidates
SODIUM HYDROXIDE	SODIUM HYDROXIDE	55X04QC32I	INJECTION / SUBCONJUNCTIVAL	ADJ PH		Exact identifier — unii candidate 174 equally ranked IID candidates
ARGININE	ARGININE	94ZLA3W45F	TABLET, FILM COATED / ORAL		25 mg	Exact identifier — unii candidate 11 equally ranked IID candidates
LACTIC ACID	LACTIC ACID	33X04XA5AT	INJECTION / INTRAMUSCULAR	1.16 %w/v		Exact identifier — unii candidate 18 equally ranked IID candidates
XANTHAN GUM	XANTHAN GUM	TTV12P4NEE	SOLUTION / OPHTHALMIC	0.6 %w/v		Exact identifier — unii candidate 29 equally ranked IID candidates
ARGININE	ARGININE	94ZLA3W45F	INJECTION / INTRAVENOUS		790 mg	Exact identifier — unii candidate 11 equally ranked IID candidates
SODIUM HYDROXIDE	SODIUM HYDROXIDE	55X04QC32I	LOTION, AUGMENTED / TOPICAL	ADJ PH		Exact identifier — unii candidate 174 equally ranked IID candidates
SODIUM HYDROXIDE	SODIUM HYDROXIDE	55X04QC32I	INJECTION / INTRAVITREAL	ADJ PH		Exact identifier — unii candidate 174 equally ranked IID candidates
SODIUM HYDROXIDE	SODIUM HYDROXIDE	55X04QC32I	TABLET, ORALLY DISINTEGRATING / ORAL		1 mg	Exact identifier — unii candidate 174 equally ranked IID candidates
SODIUM HYDROXIDE	SODIUM HYDROXIDE	55X04QC32I	INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION / INTRATHECAL	ADJ PH		Exact identifier — unii candidate 174 equally ranked IID candidates

openFDA label cross-check#

OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.

Matched openFDA labels page 1 of 1 · 1 matching rows.

Brand, Generic, Manufacturer table
Brand	Generic	Manufacturer	SPL set ID	Effective date	Available safety fields	Join
8f842c9e-fe96-43e2-a9b6-601c275eb46d			9062313f-bf8b-46df-985d-87fbc7ac9ebd	2022-02-13	Warnings	Exact identifier spl set id: 9062313f-bf8b-46df-985d-87fbc7ac9ebd

Reported adverse events (FAERS/openFDA)#

Adverse event summaries are temporarily unavailable. Other product information remains available.